Outset Medical Future Growth
Future criteria checks 1/6
Outset Medical is forecast to grow earnings and revenue by 34.2% and 11% per annum respectively while EPS is expected to grow by 35.6% per annum.
Key information
34.2%
Earnings growth rate
35.6%
EPS growth rate
Medical Equipment earnings growth | 17.1% |
Revenue growth rate | 11.0% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Further Upside For Outset Medical, Inc. (NASDAQ:OM) Shares Could Introduce Price Risks After 32% Bounce
Nov 08Outset Medical, Inc. (NASDAQ:OM) Might Not Be As Mispriced As It Looks After Plunging 27%
Sep 24Outset Medical, Inc. (NASDAQ:OM) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 11Outset Medical, Inc. (NASDAQ:OM) Stock Rockets 25% But Many Are Still Ignoring The Company
Jul 17Outset Medical: Expecting Accelerated Growth And Reduced Cash Burn Going Forward
May 28Outset Medical, Inc.'s (NASDAQ:OM) CEO Compensation Is Looking A Bit Stretched At The Moment
May 23Investors Still Aren't Entirely Convinced By Outset Medical, Inc.'s (NASDAQ:OM) Revenues Despite 30% Price Jump
May 10Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%
Feb 14Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors
Jun 09Outset Medical: Tablo Ship Hold A Key Overhang To Unlock Risk Capital
Sep 20Outset Medical awarded VA contract for hemodialysis
Aug 15Outset Medical jumps 24% after 2Q results as FDA clears hemodialysis system
Aug 01Outset Medical: Margins Leave No Tangible Value Flow, Pricing 18% Downside
Jul 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 144 | -76 | N/A | N/A | 5 |
12/31/2025 | 124 | -90 | N/A | N/A | 7 |
12/31/2024 | 112 | -121 | N/A | N/A | 7 |
9/30/2024 | 115 | -141 | -126 | -124 | N/A |
6/30/2024 | 116 | -159 | -140 | -138 | N/A |
3/31/2024 | 125 | -169 | -136 | -133 | N/A |
12/31/2023 | 130 | -173 | -135 | -131 | N/A |
9/30/2023 | 132 | -176 | -146 | -141 | N/A |
6/30/2023 | 129 | -170 | -148 | -142 | N/A |
3/31/2023 | 118 | -170 | -160 | -152 | N/A |
12/31/2022 | 115 | -163 | -154 | -146 | N/A |
9/30/2022 | 112 | -163 | -151 | -144 | N/A |
6/30/2022 | 110 | -152 | -143 | -138 | N/A |
3/31/2022 | 110 | -139 | -134 | -130 | N/A |
12/31/2021 | 103 | -132 | -133 | -130 | N/A |
9/30/2021 | 92 | -123 | -128 | -123 | N/A |
6/30/2021 | 79 | -135 | -130 | -124 | N/A |
3/31/2021 | 66 | -131 | -120 | -113 | N/A |
12/31/2020 | 50 | -79 | -108 | -99 | N/A |
9/30/2020 | 40 | -67 | -95 | -88 | N/A |
6/30/2020 | 29 | -41 | -82 | -76 | N/A |
3/31/2020 | 20 | -40 | -82 | -77 | N/A |
12/31/2019 | 15 | -85 | -74 | -70 | N/A |
12/31/2018 | 2 | -73 | -48 | -46 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OM's revenue (11% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: OM's revenue (11% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OM's Return on Equity is forecast to be high in 3 years time